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Sperm–egg bindingMolecular mechanisms by which fertilization competent acrosome-reacted sperm bind to the oolemma
remain uncharacterized. To identify oolemmal binding partner(s) for sperm acrosomal ligands, afﬁnity pan-
ning was performed with mouse oocyte lysates using sperm acrosomal protein, SLLP1 as a target. An oocyte
speciﬁc membrane metalloproteinase, SAS1B (Sperm Acrosomal SLLP1 Binding), was identiﬁed as a SLLP1
binding partner. cDNA cloning revealed six SAS1B splice variants, each containing a zinc binding active site
and a putative transmembrane domain, with signal peptides in three variants. SAS1B transcripts were
ovary speciﬁc. SAS1B protein was ﬁrst detected in early secondary follicles in day 3 ovaries. Immunoﬂuores-
cence localized SAS1B to the microvillar oolemma of M2 oocytes. After fertilization, SAS1B decreased on the
oolemma and became virtually undetectable in blastocysts. In transfected CHO-K1 cells SAS1B localized to
the surface of unpermeabilized cells. Recombinant and native SLLP1 co-localized with SAS1B to the microvil-
lar domain of ovulated M2 oocytes. Molecular interactions between mouse SLLP1 and SAS1B were demon-
strated by surface plasmon resonance, far-western, yeast two-hybrid, recombinant- and native-co-IP
analyses. SAS1B bound to SLLP1 with high afﬁnity. SAS1B had protease activity, and SAS1B protein or anti-
body signiﬁcantly inhibited fertilization. SAS1B knockout female mice showed a 34% reduction in fertility.
The study identiﬁed SAS1B–SLLP1 as a pair of novel sperm–egg binding partners involving the oolemma
and intra-acrosomal compartment during fertilization.
© 2011 Elsevier Inc. All rights reserved.Introduction
Among the events of fertilization few are more important, but as
enigmatic, as interactions between the sperm and egg membranes.
Although a few sperm proteins that bind to the mammalian oolemma
have been identiﬁed, there has been no success in identifying the
complementary oocyte binding partners for these sperm ligands.
Molecules that are posited to be involved in sperm–oolemmal bind-
ing and fusion include the ADAM family ligands and their oocyte
integrin receptors (Almeida et al., 1995; Evans et al., 1995, 1997;
Yuan et al., 1997). However, gene targeting studies have demonstrat-
ed that the sperm ADAMs including fertilin α (ADAM1), fertilin β
(ADAM2) and cyritestin (ADAM3) are important primarily for the
process of zona pellucida binding and oviduct migration rather
than for gamete fusion (Cho et al., 1998; Nishimura et al., 2001;gy, University of Virginia, P.O.
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rights reserved.Shamsadin et al., 1999). Attention has also focused on tetraspanins
(e.g., CD9, CD81), GPI-anchored proteins, and PIG-A all of which are
expressed on oocytes. However, data suggest that these proteins are
important for the sperm–oocyte fusion step, not for the binding pro-
cess (Alﬁeri et al., 2003; Coonrod et al., 1999; Miyado et al., 2000).
Although CD9−/− female mice produced eggs that matured normally,
sperm–egg fusion failed in these animals (Kaji et al., 2000; Le Naour
et al., 2000). Targeted disruption of CD81 resulted in a 40% reduction
in fertility of female mice and female mice lacking both CD9 and CD81
were completely infertile, indicating their complementary roles in
sperm–egg fusion (Rubinstein et al., 2006). It is noteworthy that
sperm ligands that interact with oolemmal tetraspanins have not
been identiﬁed.
Epididymal protein DE (CRISP1) has also been implicated in
sperm–oocyte fusion (Cohen et al., 2000) and a speciﬁc binding
region within CRISP1 was mapped. However, CRISP1 knockout male
and female mice showed no differences in fertility compared to con-
trols (Da Ros et al., 2008). Recently, Izumo, an Ig-domain molecule
localized within the acrosome was shown to be essential for sperm–
egg fusion (Inoue et al., 2005) although its oolemmal binding partner
remains unknown.
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ners for sperm ligands and with the aim of characterizing molecular
targets for contraception, it is necessary to identify both sperm and
oolemma speciﬁc interacting proteins involved in the process of fer-
tilization. The unique testis-speciﬁc c lysozyme-like, intra-acrosomal
transmembrane protein SLLP1, was reported to lack bacteriolytic ac-
tivity (Mandal et al., 2003), localize to mouse sperm acrosomal mem-
branes, and have oolemma binding properties (Herrero et al., 2005).
SLLP1 antibody and recombinant protein blocked in vitro fertilization
and sperm–egg binding in mice, suggesting that SLLP1 may play a role
in sperm–egg adhesion. To identify oocyte speciﬁc binding partners
for sperm ligands, sperm acrosomal SLLP1 was used as a target in af-
ﬁnity panning. This study characterizes a SLLP1 binding partner,
SAS1B, on the oolemma, and deﬁnes the timing and pattern of its ex-
pression in developing and adult ovaries, oocytes and early embryos.
SAS1B appears to be the only oocyte speciﬁc oolemmal metallopro-
tease yet implicated in sperm–oolemma binding during mammalian
fertilization.
Materials and methods
Identiﬁcation of SAS1B by surface plasmon resonance (SPR)
Cumulus and zona free mouse oocytes (n=~1000) were sus-
pended in 500 μl of Dulbecco's PBS, freeze-thawed 3 times (−80 °C
and 37 °C), and mixed. The mixtures were spun for 5 min at
13000×g, and the supernatants were passed over a Biacore Sensor
Chip CM5 (GE Healthcare, Piscataway, NJ) containing bound mouse
soluble recombinant (r) SLLP1 (binding concentration used at 1 μg/
μl, 200 μl) or no SLLP1 (negative control) at a ﬂow rate of 10 μl/min
at 25 °C. The chips were then washed in PBS and eluted in 5 μl of
0.1% triﬂuoroacetic acid at a ﬂow rate of 12 μl/min at 25 °C. For each
SPR analysis, 7 to 10 samples bound to the chip were collected and
pooled. The pooled samples (size ~35 to 50 μl), were digested with
trypsin and analyzed by mass spectrometry in the Biomolecular Re-
search Facility (BRF) at the University of Virginia. Two oocyte speciﬁc
SAS1B peptides were identiﬁed.
Expression and puriﬁcation of mouse SAS1B, SLLP1, and Ecat1
BLAST analysis of the 2 peptides identiﬁed by SPR matched a hypo-
thetical 414 amino acid mouse protein, GenBank accession NP_766127.
Amouse ovarian cDNA library (Ambion, Austin, TX)was ampliﬁedwith
gene-speciﬁc forward (5′GGAATT CCA TATGGGAGCACC CTCAGCATC
CAG A 3′) and reverse primers (5′ ATA GTT TAG CGG CCG CGT CTC TGG
GCA CCT CTC TAA TGT G 3′) containing NdeI and NotI restriction sites,
respectively (Invitrogen, Carlsbad, CA). The 40 cycle PCR product
(~1200 bp) was subcloned in pCR2.1-TOPO vector (Invitrogen). The
insert was used to express recombinant (r) protein from pET28b+
vector following transformation of BL21DE3 cells and the expressed
protein was puriﬁed by afﬁnity column chromatography as described
earlier (Herrero et al., 2005; Mandal et al., 2003). Mouse rSLLP1 was
puriﬁed as described previously (Herrero et al., 2005).
Mouse Ecat1 (Filia/2410004A20Rik) speciﬁc forward (5′ CAT GCC
ATG GCC TCT CTG AAG AGG TTT CAG 3′) and reverse primers (5′ CCG
CTC GAG TAA TAT GAT AAA TGA TTC CCA GGC 3′) containing NcoI
and XhoI restriction sites, respectively were used to amplify cDNA
encoding the full length protein (440 amino acids) frommouse ovarian
cDNA (Ambion). The PCR ampliﬁed product was sequenced, and
recombinant mouse Ecat1 protein was expressed and puriﬁed as
described above and used as a negative control in IVF assays.
Polyclonal antibody production and Western analyses
Following collection of pre-immune sera by heart puncture, adult
male guinea pigs were immunized with 150 μg of puriﬁed rSAS1B incomplete Freund's adjuvant, boosted twice at intervals of 21 days
with 150 μg of rSAS1B in incomplete Freund's adjuvant, and serum
was collected as described previously (Herrero et al., 2005). Speciﬁc-
ity of the antibody was tested against rSAS1B and mouse oocyte
extracts. rSAS1B protein (125 ng/lane) or oocytes (~150/lane) were
solubilized in 2× Laemmli buffer, resolved on 12.5% SDS-PAGE
Criterion gels (Bio-Rad, Hercules, CA), blotted to nitrocellulose mem-
brane (0.2 μm, Bio-Rad) and blocked with 5% nonfat dry milk in phos-
phate buffered saline (PBS) with 0.05% Tween 20 (PBST) for 45 min at
room temperature. The blots were then probed with primary anti-
body (1:5000 for rSAS1B, 2 h; 1:1000 for oocytes, overnight), washed
10 min in PBST (3×), and incubated with peroxidase-conjugated don-
key or goat anti-guinea pig IgG secondary antibody (1:5000 for
rSAS1B, 1:2500 for oocytes) for 1 h. The blots were washed in PBST
(10 min, 2×), in PBS (10 min, 3×) and then developed in TMB perox-
idase substrate (KPL, Gaithersburg, MD).
Protease activity assay of rSAS1B
Protease activity was assayed in serial dilutions (0–2000 ng) of
puriﬁed bacterial recombinant SAS1B using the EnzChek® Peptidase/
Protease Assay Kit (Molecular Probes, Eugene, OR), which provides a
FRET (ﬂuorescence resonance energy transfer) -based method for
quantitation of a wide range of protease activities. This assay was per-
formed in 100 μl size reactions using a constant substrate concentration
and repeated three times with varying concentrations of recombinant
SAS1B. Fluorescence was measured after 24 h of incubation at room
temperature (23–25 °C) following the manufacturer's protocol. Prote-
ase activity of recombinant SAS1B appeared within 1 h and increased
within 24 h. rSLLP1 was used as a negative control. The assay method
was validated using puriﬁed trypsin as a positive control (Sigma).
Immunohistochemistry (IHC) of SAS1B
Newborn (days 0–7), pubertal (day 14) and adult mouse
(day≥56) ovaries were ﬁxed in Bouin's ﬁxative and embedded in
parafﬁn. Sections were heated at 56 °C, deparafﬁnized in xylene and
endogenous peroxidase activity was quenched followed by rehydra-
tion. Sections were then blocked with 5% non-fat dry milk in PBS
(NFDM-PBS) containing 5% normal goat serum for 1 h at room tem-
perature and probed with immune or pre-immune antibody (dilution
1:200) in blocking solution at 4 °C overnight in a humid chamber. The
slides were washed in PBS (×3) and probed with HRP-labeled goat
anti-guinea pig secondary antibody (Jackson ImmunoResearch,
West Grove, PA) diluted (1:1000) in 1% NFDM-PBS for 1 h at room
temperature in a humid chamber. After washing, the immunoperoxi-
dase color reaction was developed by using 3,3′-diaminobenzidine
substrate (Sigma), counterstained with hematoxylin for 3 min, dehy-
drated through an increasing series of alcohol concentrations, cleared
in xylene and mounted in DPX medium (Sigma). Slides were exam-
ined on a Zeiss Axioscope microscope (Carl Zeiss, GmbH, Germany).
Indirect immuno-ﬂuorescence (IF) microscopy of oocytes and early
embryos
Metaphase II eggs and subsequent embryonic stages including 2,
4, 8 cells and blastocyst stages were collected and blocked in 5%
NGS/TYH media for 30 min. Samples were then incubated with
SAS1B antibody (1:200) in 0.1%NGS/media for 1 h at 37 °C, 5% CO2.
Preparations were washed ﬁve times and incubated with goat anti-
guinea pig/Cy3 red antibody (1:200, Jackson ImmunoResearch) in
0.1% NGS/media for 1 h at 37 °C, 5% CO2, washed again, mounted in
media on glass slides, and visualized under a Zeiss Standard 18 ultra-
violet microscope.
For rSLLP1 co-localization, oocytes were incubated with 10 μg/ml
of rSLLP1 for 1 h, washed 5× and incubated with guinea pig SAS1B
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0.1% NGS/media for 1 h. Oocytes were then washed 5× and incubated
with goat anti-guinea pig/Cy3 red antibody (1:200) and goat anti-rat/
FITC green antibody (1:200; Jackson ImmunoResearch), in 0.1% NGS/
media for 1 h. Oocytes were washed and mounted in media on glass
slides. SLLP1 and SAS1B images were captured separately with
MrGrab 1.0 (Carl Zeiss Vision) on the Zeiss Standard 18 ultraviolet
microscope and were merged digitally to evaluate their respective
localizations.
For native (n) SLLP1 co-localization with SAS1B, oocytes were in-
cubated with acrosomal extract prepared from cauda sperm capaci-
tated for 90 min and acrosome reacted for 15 min in 5 μM calcium
ionophore A23187 (Herrero et al., 2005). Exocytosed acrosomal su-
pernatant material was collected at 16000×g for 10 min and dialyzed
in PBS for 4 h. Ten microliters were used in 100 μl fertilization media
containing zona-intact oocytes as described above for 1 h at 37 °C in
5% CO2. The eggs were then washed and probed with rat SLLP1 and
guinea pig SAS1B antibodies and respective 2 secondary antibodies
(anti-rat/Cy3 red; anti-guinea pig/FITC green).
Scanning confocal microscopy of eggs and early embryos
Mouse oocytes and early embryos were also studied by scanning
confocal microscopy. The stained preparations were washed three
times in PBS containing 1% BSA (PBS/BSA) and then ﬁxed in 4% para-
formaldehyde in PBS-polyvinylalcohol (PVA) for 20 min at room tem-
perature. Following ﬁxation, oocytes and embryos were washed 5
times in PBS/BSA and permeabilized with 0.5% Triton X-100 in PBS
for 20 min at room temperature. Specimens were washed ﬁve times
in PBS/BSA, placed in 0.4 mg/ml RNase (Sigma) in PBS/BSA for
30 min, and stained with 20 nM Sytox (Molecular Probes) for
10 min. Oocytes and embryos were then extensively washed, placed
in slow-fade equilibration media (Molecular Probes) for ~1 min, and
mounted on slides in slow fade mounting media. Images were
obtained on a Zeiss 410 Axiovert 100 microsystems LSM confocal
microscope. For each panel, 4-s scans were averaged four times per
line using a 63× oil lens equipped with a zoom factor of two.
Attenuation, contrast, brightness, and pinhole aperture remained
constant.
Northern analysis of SAS1B mRNA
Mouse multiple tissues Northern blots (total RNA, ~20 μg/lane)
were obtained commercially (Zyagen, San Diego, CA). The Northern
membrane was blocked in ExpressHyb hybridization solutions
(Clontech, Mountain View, CA) at 68°C for 1 h in hybridization oven
(GE Healthcare). The blot was then probed with fresh hybridization
solution containing 32P-dCTP labeled SAS1B ORF cDNA (4.3 ng/ml)
for 2 h at 68 °C. The membrane was washed in wash solutions I and
II as described earlier (Naaby-Hansen et al., 2002). The membrane
was then exposed to phosphor screen for 24 to 72 h, imaged using
PhosphorImager (Storm 820, GE Healthcare) and analyzed by
ImageQuant software. The same membrane was stripped at 0.5% SDS
in sterile water for 10 min at 90–98 °C and probed with 32P-dCTP
labeled GAPDH cDNA as a positive control.
Localization of SAS1B in transformed CHO-K1 Cells
Full length SAS1B was cloned into pcDNA3.1/V5/His-TOPO vector
(Invitrogen) from a PCR product generated from a mouse ovary
cDNA library (Ambion) using gene-speciﬁc forward (5′ ATG GGT
ATC ATG GGA AGC CTG TGG 3′) and reverse primers (5′ GTC TCT
GGG CAC CTC TCT AAT GTG 3′). Adherent Chinese hamster ovary
(CHO-K1) cells maintained in Ham's F-12 nutrient medium (F12-
Ham 1X; Invitrogen, containing 10% fetal calf serum, 1 mM sodium
pyruvate) at 37 °C in humidiﬁed 5% CO2 were used for transfectionat ~50–70% conﬂuence. Before transfection, cells were seeded on 6-
well plates containing poly-D-lysine coated 12 mm round coverslips
and transfected with Lipofectamine™ 2000 for 5 h at 37 °C (pDNA:
lipofectamine; 4 μg:10 μl, per well) in 500 μl of Opti-MEM (Invitro-
gen) followed by incubation in fresh F12 media for 48 h.
The cells were ﬁxed brieﬂy with 4% paraformaldehyde in PBS,
blocked with 10% FBS (Fetal Bovine Serum) in PBS for 30 min, and a
cohort was permeabilized with 0.05% NP-40. Cells were incubated
with SAS1B antibody for 1 h or mouse anti-V5 tag monoclonal anti-
body, and immune-complexes were visualized with FITC-donkey
anti-guinea pig or mouse antibody (Jackson ImmunoResearch).
Cover slips were mounted with slowfade (Molecular Probes), sealed
with nail polish, and visualized by ultraviolet microscopy as noted
above.
Far-Western analysis
Puriﬁed recombinant SAS1B was resolved by SDS-PAGE and trans-
ferred to nitrocellulose membranes. The membrane was probed with
c-terminal anti-his monoclonal antibody and developed with TMB.
Duplicate SAS1B blotted strips were blocked and overlaid with
mouse rSLLP1 or not, 5 μg/ml in blocking buffer i.e., 5% milk in PBS
with 0.05% Tween 20 [PBST] for 90 min at room temperature. Follow-
ing overlay, the strips were washed in PBST and incubated with anti-
SLLP1 (ADD2) monoclonal antibody for 1 h in blocking buffer. After
washing in PBST (×4), the strips were probed with goat anti-mouse
HRP secondary antibody in blocking buffer for 1 h, washed in PBST
(×4) followed by PBS (×1), and developed with TMB.
In vitro translation and co-immunoprecipitation (co-IP)
The pGADT7 and pGBKT7 expression plasmids (Clontech), which
encode N-terminal HA and c-Myc epitopes, respectively, were used
to produce rSLLP1 and rSAS1B proteins in vitro, utilizing the Quick
Coupled Transcription/Translation (TNT) system (Promega, Madison,
WI). The TNT reactions were performed for 90 min at 30 °C using
plasmid (≤2 μg), TNT reagents, rabbit reticulocyte lysate, and 35S-
methionine (GE Healthcare) in 50 μl aliquots as per manufacturer's
protocol. The radiolabeled proteins (5 μl of TNT product in 2× reduc-
ing sample buffer) were resolved by 15% SDS-PAGE Criterion gels,
ﬁxed (50% methanol, 10% glacial acetic acid) for 30 min, equilibrated
in 10% glycerol (with 20% ethanol) for 30 min, air dried for 1 h (GelAir
drying system, Bio-Rad) and exposed to phosphor screens.
For Co-IP reactions, the speciﬁc TNT products, ranging from 7 to
23 μl were gently mixed for 1 h at 4 °C. Simultaneously the anti-c-Myc
and anti-HA antibody coupled agarose beads (Profound IP/Co-IP sys-
tem, Pierce) were blocked in 5% milk in PBST for 1 h at 4 °C in Handee
spin columns (Pierce). The antibody beads were incubated with IP or
Co-IP samples overnight at 4 °C with gentle end-over-end mixing. The
beads were then washed 3× in 500 μl of PBST at 4000×g for 10 s with
3 gentlemixes during eachwash. The IP and Co-IP products were eluted
from beads in 23 μl of 2× non-reducing sample buffer, heated (99 °C,
5 min), centrifuged, mixed with 2 μl of β-mercaptoethanol, and 20 μl
loaded per lane for SDS-PAGE analysis. The gels were ﬁxed, air dried,
exposed to phosphor screens, and imaged as described above.
Yeast two-hybrid (Y2H) analysis
The mature mSLLP1 protein (C-terminal 128 residues) was cloned
as a fusion to the GAL4 activation domain in the pGADT7 vector while
full length SAS1B (414 residues), N-terminal SAS1B (121 residues),
and C-terminal SAS1B (210 residues) proteins were each fused to
the GAL4 DNA-binding domain in the pGBKT7 vector utilizing EcoRI
and BamHI sites (Yeast two-hybrid system 3, Clontech). Competent
strain AH109 yeast cells were transformed with single, double or
empty constructs, and plated on low (LS) and high stringency (HS)
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both plasmids, which supplied the deﬁcient amino acids (tryptophan
and leucine from pGBKT7 and pGADT7 vectors, respectively). The HS
plates, deﬁcient in adenine and histidine in addition to tryptophan
and leucine, were used for evaluation of interaction between the
test plasmids. This Y2H system 3 uses the expression of three reporter
genes – ADE2, HIS3, and MEL1 (or LacZ) – under the control of GAL4
upstream activating sequences and TATA boxes. The ADE2 and HIS3
reporters provide strong nutritional selections to the yeast strain,
AH109. Furthermore, the expression of MEL1 gene, which encodes a
secretory α-galactosidase, was used to screen and visualize the blue
colonies indicative of positive interaction by incorporating X-α-gal
into the culture plates. The cells were grown at 30 °C for 5 to 6 days.
The experiments were repeated 3 times.
Native SAS1B co-IP
Mouse cauda (n=10) epididymal sperm and cumulus free zona-
intact (55%) and zona-free (45%) oocytes (n=2069) were extracted
in RIPA buffer in presence of complete protease inhibitors (Roche,
Indianapolis, IN). The sperm (450 μl) and egg extracts (95 μl) were
mixed (3 h, 4 °C, ×2), incubated with rat SLLP1 preimmune or
immune antibody (3 h) and treated with 70 μl of protein G-agarose
beads (Roche) overnight at 4 °C. The beads were then washed in the
presence of protease inhibitors in wash buffer 1 (20 min, ×2), wash
buffer 2 (20 min, ×2) and wash buffer 3 (20 min, ×1). The IP com-
plexes were then eluted in 75 μl 2× Laemmli sample buffer, divided
equally, resolved in 15% or 10% SDS-PAGE, blotted and probed with
guinea pig SLLP1 or SAS1B antibodies. Additionally, the IP blots
were stripped (Pierce) and again probed with a rabbit anti-human
SAS1B pro-peptide antibody (Abcam, Cambridge, MA).
Afﬁnity between SLLP1 and SAS1B
The protein–protein interaction afﬁnity between SLLP1 and SAS1B
in terms of dissociation constant (KD) was determined by surface
plasmon resonance with a Biacore 3000 system (GE Healthcare). A
CM-5 sensor (carboxylated dextran matrix) chip was activated with
a 1:1 mixture of 75 mg/ml 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide and 11.5 mg/ml N-hydroxysuccinimide for 7 min. Brieﬂy,
mouse rSLLP1 (60 μg/ml in 10 mM sodium acetate pH 4.0) was
injected over an activated CM-5 chip for 7 min at a ﬂow rate of
10 μl/min at 25 °C. Remaining active groups on the matrix were
blocked in 1 M ethanolamine at pH 8.5. Coupling of SLLP1 on CM-5
sensor chip resulted in a surface concentration of ~10 ng/mm2.
Protein solutions of SAS1B (0, 25, 50, 100, 200, 300, 400 nM) were
prepared in 10 mM HEPES buffer, pH 7.4, 150 mM NaCl, 3 mM
EDTA, 0.0025% surfactant P20 (running buffer) and injected for
3 min at a ﬂow rate of 30 μl/min. After 15 min for dissociation, the
surface was regenerated with 10 mM glycine–HCl buffer, pH 3.0, for
60 s followed by a 15 min wash in running buffer at 30 μl/min. The ﬁt-
ting of association and dissociation curves according to a 1:1 binding
model was used for the calculation of kinetic constants (Biaevaluation
software version 4.1).
In vitro fertilization (IVF)
ICR mice were used in all experiments. All animals were handled
according to institutional guidelines. Epididymal sperm and oocytes
were collected as described previously (Herrero et al., 2005). For eval-
uation of rSAS1B effect on IVF, cauda sperm were placed for 5 min in
200 μl drops of fertilization medium under parafﬁn oil. The sperm
suspension was diluted to a concentration of 106 sperm/ml in a vol-
ume of 200 μl and then incubated for 120 min in a humidiﬁed tissue
culture incubator (37 °C, 5% CO2 in air) to allow capacitation. The
spermatozoa were incubated with varying concentrations of puriﬁedrSAS1B (0–100 μg/ml PBS) or puriﬁed mouse Ecat1 (50 μg/ml PBS) or
PBS only for the last 60 min of capacitation. One cumulus mass was
placed in 135 μl drop of fertilization medium under parafﬁn oil, and
15 μl of the sperm suspension (ﬁnal: 105 sperm/ml) was added to
each drop. Six hours following insemination, oocytes were relocated
to 100 μl drops of fertilization medium under mineral oil. Following
overnight incubation, eggs were stained in 10 μg/ml Hoechst dye for
10 min, washed 3 times in fertilization medium and examined as
described earlier (Herrero et al., 2005). Two-cell embryos and eggs
with double pronuclei (representing only 1 to 2% of fertilized eggs)
were scored as fertilized, while one-nucleus oocytes were scored as
unfertilized. For evaluation of antibody effects, cumulus free zona-
intact oocytes were treated with SAS1B preimmune or immune anti-
body at 1:20 or 1:60 dilutions for 1 h followed by insemination with
capacitated sperm and scored for fertilization as described above.
Generation of SAS1B deﬁcient mice
The SAS1B protein is encoded by the Astl gene (astacin-like metal-
loendopeptidase). The Astl knockout mice were obtained from
Lexicon Pharmaceuticals (The Woodlands, TX). Brieﬂy, the employed
methods were as follows. The Astl targeting vector was derived using
long-range PCR to generate the 5′and 3′ arms of homology using
129S5 ES cell DNA as a template. The 4940 bp 5′ arm was generated
using primers Astl-3 (5′- AAT GGC GCG CCT CAA GAT AAT TAG CAT
ATC CAT CGG -3′) and Astl-2 (5′- TAA ATG GCC GCT ATG GCC GAG
AGA GGG CAG CTC AGA GTT AAA T -3′) and cloned using the TOPO
(Invitrogen) cloning kit. The 2869 bp 3′ arm was generated using
primers Astl-7 (5′- TTA ATG GCC AGC GAG GCC CTC AGG CCA GGG
CTG GAG TTG AGG A -3′) and Astl-9 (5′- AAT GGC GCG CCC CCA
TAA TGC ATC ACA GAT GAG TAG -3′) and cloned using the TOPO clon-
ing kit. The 5′ arm was excised from the holding plasmid using AscI
and SﬁI. The 3′ arm was excised from the holding plasmid using SﬁI
and AscI. The arms were ligated to an Sﬁ I prepared selection cassette
containing a negative selection marker thymidine kinase (TK), a
Betagalactosidase (LacZ) marker along with a MC1 promoter driven
Neomycin (Neo) resistance marker and inserted into an AscI cut
pKO Scrambler vector (Stratagene) to complete the Astl targeting
vector which resulted in the deletion of exons 5, 6 and 7 (NCBI geno-
mic accession NT_039207.7) encoding a total of 131 residues (SPF–
ILP), including the putative transmembrane and the catalytic do-
mains. The Not I linearized targeting vector was electroporated into
129S5 ES cells. G418/FIAU resistant ES cell clones were isolated, and
correctly targeted clones were identiﬁed and conﬁrmed by Southern
analysis using a 243 bp 5′ external probe (18/19), generated by PCR
using primers Astl-18 (5′- AGG CCT TTG ACT TTG TTA AGC A -3′)
and Astl-19 (5′- CCA TAT CAG AGC AGC CGT CAT C -3′) and a
484 bp 3′ external probe (20/21), ampliﬁed by PCR using primers
Astl-20 (5′- TTG CCA AGC ATC TGT GAT CCT A -3′) and Astl-21 (5′-
CAG GTC TGC ATT GCC ATA CCA G -3′). Southern analysis using 5′-
probe detected a 10.1 kb wild type band and 8.4 kb mutant band in
ApaLI digested genomic DNA while 3′-probe detected a 7 kb wild
type band and 12 kb mutant band in ApaI digested genomic DNA.
Six targeted ES cell clones were identiﬁed and microinjected into
C57BL/6 (albino) blastocysts to generate chimeric animals which
were bred to C57BL/6 (albino) females, and the resulting heterozy-
gous offspring were interbred to produce homozygous Astl deﬁcient
mice.
Genotyping and fertility evaluation of SAS1B knockout mice
Genomic DNA was extracted from tail tips of mice using Sigma
Redextract-N-amp reagents (Sigma-Aldrich) and their genotypes
were determined by PCR with a mixture of three primers (exon 7
forward, WF: 5′- GCT TCT GGC ATG AGC ATT CA -3′; neo forward,
NF: 5′- CGT TGG CTA CCC GTG ATA TTG -3′; intron 7 reverse, WR:
44 M. Sachdev et al. / Developmental Biology 363 (2012) 40–515′- GGA CAC TGC CAA CCT CAC ATT -3′). The PCR conditions were
35 cycles of 94 °C for 30 s, 59 °C for 30 s and 72 °C for 90 s. In vivo fer-
tility of was evaluated by caging 2 females (−/−, +/+) with 1 male
(+/+) for two weeks. The females were then caged separately for
fetal or litter size count. For determination of fetal count, the female
mice were sacriﬁced on day 15 of pregnancy.
Statistical methods
All in vitro fertilization assays were done 3 or more times. Expe-
rimental and control groups were reported as mean±standard
error of mean. Statistical signiﬁcance between the groups was
analyzed by unpaired Student's t-test assuming equal variances and
differences were reported at P≤0.05 as the level of signiﬁcance.
Results
Identiﬁcation of SAS1B
To identify putative oolemmal partner(s) for SLLP1, ligand afﬁnity
panning was performed with mouse egg lysate using immobilized
rSLLP1 on a Biacore sensor chip. Peptide analysis of eluted proteins
matched to several proteins including an un-annotated gene which
showed a pattern of ESTs in the GenBank database indicating restrict-
ed expression in ovary, oocytes and zygote. The protein was designat-
ed sperm acrosomal SLLP1 binding, SAS1B. Six SAS1B splice variants
were cloned and deposited to GenBank (Supplementary Fig. 1). All
six variants contained the zinc binding active site motif, a characteristic
of zinc dependent metalloproteases, and a putative transmembrane
domain. Three SAS1B variants (V1, V4, V6) revealed a putative signal
sequence followed by a predicted cleavage site between residues
SMG-AP. SAS1B variants revealed deletions of 34 residues from exons
4 and 5 (V3, V4) or deletion and insertion in exon 5 (V5, V6). SAS1B
was found to be conserved among mammals (Supplementary Fig. 2,
67% identity to human) and its homologs can be traced to lower inver-
tebrates (identity, 42% zebraﬁsh; 36% nematode). Alignment revealed
conservation of signal peptide and the zinc binding signatures.
SAS1B isoforms and protease assay
The rSAS1B (V2), expressed in Escherichia coli with a histidine tag
and puriﬁed by afﬁnity column chromatography, revealed two major
bands (~50 and ~25 kDa) and several minor bands (Fig. 1A, L4). Each
of the afﬁnity puriﬁed bands identiﬁed by Coomassie was conﬁrmedFig. 1. Expression, puriﬁcation, Western and protease activity of rSAS1B. (A) The mature p
stained with Coomassie; protein standards (L1). All puriﬁed bands were conﬁrmed as rSAS
proteins from ~54 to ~31 kDa in zona intact (L6) and zona free (L7) oocyte protein extracts
and L9). (B) Assay of protease activity of rSAS1B (♦) using a ﬂuorescent tagged synthetic pep
system. rSLLP1 (■) was used as a negative control.by anti-his tag monoclonal antibody Western (Fig. 1A, L5). The
~25 kDa band was found by Edman degradation to be a 210 residue
C-terminal fragment that begins at aa 205 (V2, Supplementary Fig.
1). The C-terminal fragments appear to result from proteolysis during
puriﬁcation.
SAS1B antibody recognized the recombinant (Supplementary Fig.
3A, L2), and the native SAS1B in egg protein extracts. Zona-intact
and zona-free mouse egg extracts showed essentially identical micro-
heterogeneity of immunoreactive bands of native SAS1B between ~54
and ~31 kDa (Fig. 1A, L6, L7), with major bands of ~45/44 (V2, V6,
V4) and ~31 kDa, and minor bands of ~54, ~51, ~48 (V1), and ~41/
42 kDa (V3, V5). Pre-immune control antibody showed no immuno-
reactivity with egg protein extracts (Fig. 1A, L8, L9) or rSAS1B (Sup-
plementary Fig. 3A, L1). SAS1B protein micro-heterogeneity likely
corresponds to the six splice variants, which are predicted to encode
proteins of 47.5 (V1), 45.2 (V2), 41.4 (V3), 43.7 (V4), 42.4 (V5) and
44.8 (V6) kDa, while the lower ~31 kDa protein may be a processed
form. Protein heterogeneity of the splice variants was conﬁrmed by
comparing the masses of three SAS1B isoforms (V2, V3, and V5)
expressed in E. coli, resulting in the expected molecular weight differ-
ences (data not shown). The presence of masses higher than those
deduced from primary sequences may suggest possible post-
translational modiﬁcations of SAS1B isoforms. All SAS1B variants
revealed two putative N-glycosylation sites (aa 266, 280, V1).
Puriﬁed rSAS1B was tested for protease activity using a ﬂuorescent
conjugated synthetic peptide substrate (Fig. 1B). rSAS1B exhibited con-
centration dependent proteolytic activity assayed by ﬂuorescence reso-
nance energy transfer (FRET) over the range 200–2000 ng. rSAS1B
demonstrated protease activity within 1 h (Supplementary Fig. 3B)
and ﬂuorophore conjugated substrate hydrolysis was linear with
respect to concentration at 24 h (Fig. 1B). Mouse rSLLP1 puriﬁed by
identical procedures to rSAS1B from the same E. coli strain showed no
enzymatic activity. This result indicated that E. coli expressed rSAS1B
refolded sufﬁciently to retain proteolytic activity.
SAS1B expression in ovary and oocyte
To follow SAS1B ontogeny, ovaries from postnatal (PN) days 0, 1.5,
2, 3, 4, 7, 14, 28 and 56 were studied by immunohistochemistry (IHC).
SAS1B protein was ﬁrst detected in the ooplasm of early bilaminar
secondary follicles beginning with PN day 3 (Fig. 2A2). SAS1B was
not detected in naked oocytes, oocytes in primordial or unilaminar
primary follicles, or in any other ovarian cells at pre-pubertal, puber-
tal or adult stages (Fig. 2A). SAS1B expression was localized only in
secondary, antral and Graaﬁan follicle oocytes.rotein was expressed in E. coli, uninduced (L2), induced (L3), puriﬁed (L4, 3 μg) and
1B by anti-His tag Western analysis (L5). SAS1B antibody recognized a range of native
but no proteins were identiﬁed with preimmune antibody in the identical extracts (L8
tide as substrate. Varying concentrations of puriﬁed proteins were used in 100 μl assay
Fig. 2. Localization of SAS1B in developing ovary by IHC and in M2 oocytes by IF. (A) SAS1B expressed in ooplasm of secondary (S) follicles beginning in day 3 ovary (A2). No SAS1B
was detected in naked oocytes (A1), primordial (M) and primary (P) follicles (A5). Panels 1, 2, 3, 4, 5 and 6 represent postpartum ovaries at days 0, 3, 7, 14, 56 and 14 respectively.
Preimmune control, A6. (B) In unpermeablized zona-intact ovulated M2 oocytes, SAS1B was concentrated in a dome shaped microvillar domain on the surface of the oocyte plasma
membrane. Eccentric nuclei (blue) were antipodal to the SAS1B positive domain. Preimmune control panels: 4, 5 and 6. Panels: 1 and 4, phase; 2 and 5, ﬂuorescence; 3 and 6,
merged image of DAPI/ﬂuorescence.
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lated M2 secondary oocytes prior to fertilization showed that SAS1B
was localized asymmetrically on the oocyte surface (Fig. 2B and Sup-
plementary Fig. 4A), being concentrated in a dome corresponding to
the microvillar region of the oolemma (Evans et al., 1997) which is
antipodal to the eccentric nucleus.
Tissue speciﬁcity of SAS1B mRNA
A 32P labeled SAS1B ORF cDNA of V2 was used to probe Northern
blot containing total RNA from 15 mouse tissues. A single band ofFig. 3. Tissue expression of SAS1B transcript. A 15 mouse tissue Northern blot containing tota
in ovary (lane 9). Same blot probed with GAPDH cDNA as control (B). Tissues: 1, brain; 2, sto
spleen; 12, testis; 13, thymus; 14, uterus; and 15, placenta.~3.0 kb size was observed only in ovary indicating ovary speciﬁc
expression of SAS1B transcript (Fig. 3A). Reprobing of the blot with
mouse GAPDH cDNA conﬁrmed integrity of RNA samples.
SAS1B confocal localization in oocyte and early embryo
In ovulated GV stage oocytes, SAS1B was observed throughout the
ooplasm with enrichment at the oocyte periphery (Fig. 4, GV). In M2
oocytes, SAS1B was concentrated in the microvillar domain of the
oolemma antipodal to the nucleus and in the membrane of the ﬁrst
polar body. These observations imply that during the GV to M2l RNA probed with 32P labeled SAS1B cDNA revealed a SAS1B mRNA of ~3.0 kb (A) only
mach; 3, intestine; 4, colon; 5, liver; 6, lung; 7, kidney; 8, heart; 9, ovary; 10, muscle; 11,
Fig. 4. Confocal localization of SAS1B before and after fertilization. Oocytes and cultured early embryos stained with SAS1B antibody (red) and with Sytox (for nucleus, green, upper
panel; merged on phase images, lower panel). SAS1B was localized throughout the cytoplasm of the GV oocyte where it concentrated at the cell periphery. After polar body forma-
tion, in M2 oocyte SAS1B localized mainly in the microvillar domain of oolemma. In fertilized oocyte (PN-II), SAS1B was located only in punctate regions at the cell periphery. These
small patches persisted from 2-cell to morula stages when SAS1B appeared within the PVS. SAS1B was virtually undetectable in blastocyst stages.
Fig. 5. SAS1B expression on the cell surface of transfected CHO-K1 cells. (A) In ﬁxed and
permeabilized cells SAS1B localized to cytoplasmic and surface domains. (B) Polarized
localization (arrows) of SAS1B at the cell surface in ﬁxed, unpermeabilized cells con-
ﬁrmed that SAS1B is a membrane protein. (C) Fixed and permeabilized cells probed
with SAS1B C-terminal V5 tag antibody showing its presence in the cytoplasm. Panels:
left, phase; right, ﬂuorescence. The control cells (A1, B1, C1) that were transfected with
the respective pcDNA3.1-TOPO vector lacking a SAS1B construct were probed with
SAS1B speciﬁc antibodies revealing no immunoﬂuorescence.
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takes place. Observations of zygotes with two pronuclei revealed that
SAS1B was no longer polarized in the microvillar domain but now
showed only weak staining of the plasma membrane (PN-II). In 2-
cell through morulae stages diffuse, punctuate SAS1B staining was
observed mainly in the perivitelline space (PVS), but occasionally on
the oolemma. This low level of punctate staining remained mainly
in the PVS through the early blastocyst stage and then dis-
appeared in late blastocyst stages. Thus, SAS1B demonstrated the
greatest intensity of staining on the plasma membranes of GV and
M2 oocytes.
SAS1B is a membrane protein
Full length SAS1B with a C-terminal V5 tag was expressed in
mammalian CHO-K1 cells and the protein was localized in permeabi-
lized and unpermeabilized transfected cells by IF. SAS1B antibody
localized SAS1B in the cytoplasm and on the cell membranes of per-
meabilized cells and at the cell membrane of unpermeabilized cells
(Figs. 5A, B). Interestingly, SAS1B was concentrated asymmetrically
in unpermeabilized transfected cells, where SAS1B localized in re-
gions where blebs and lamellipodia were noted by phase contrast
microscopy (arrows). Unpermeable CHO-K1 cells did not stain with
C-terminal V5 antibody (data not shown), whereas permeable cells
did stain (Fig. 5C). The results suggested that the C-terminus of
SAS1B is cytoplasmic and the N-terminus is extracellular in orienta-
tion. Together, these observations support the conclusion that
SAS1B is a protein that translocates to the plasmalemma. The respec-
tive control cells transfected with blank vector showed no staining
(Figs. 5, A1, B1, C1).
Protein–protein interactions between SAS1B and SLLP1
SPR and Far-Western (FW) analyses
As noted earlier, SAS1B was ﬁrst identiﬁed by SPR from egg pro-
tein extract as a putative partner protein for the sperm acrosomal
ligand SLLP1 (Supplementary Fig. 1). Next, afﬁnity between SAS1B
and SLLP1 was studied by FW analysis with puriﬁed rSAS1B and
rSLLP1. SAS1B was transferred to nitrocellulose membranes. A
rSAS1B blot probed with anti-His tag monoclonal antibody identiﬁed
the speciﬁc rSAS1B bands (Fig. 6, FW, L2), including the full length
and truncated proteins. Additional blots were either overlaid or not
with rSLLP1, washed and probed with SLLP1 monoclonal antibody
(Fig. 6, FW). The FW revealed that SLLP1 interacted strongly with
the full length SAS1B doublet (~51, ~50 kDa) but very weakly withthe C-terminal fragment (~25 kDa) indicating that the SAS1B
N-terminus is more important to the conformation responsible for
the SLLP1 binding domain than the C-terminus alone.
Fig. 6. SAS1B–SLLP1 interactions by Far-Western (FW) and rCo-IP (A) analyses. (FW) Proﬁle of puriﬁed rSAS1B stained with Coomassie used for FW analysis (L1). Western of
rSAS1B probed with anti-his tag antibody (L2). rSAS1B blot either overlaid (L3) or not overlaid (L4) with puriﬁed soluble rSLLP1 (5 μg/ml) and probed with anti-SLLP1 monoclonal
antibody. Full length SAS1B (~51, ~50 kDa) bound to rSLLP1; however, the C-terminal ~25 kDa protein band of similar intensity bound rSLLP1 only very weakly. (A) rCo-IP of SLLP1
using SAS1B myc-tag (M) antibody. Proteins were synthesized by in vitro translation in presence of S35-methionine and analyzed by SDS-PAGE. Translated SAS1B full length (F), N-
terminus (N), C-terminus (C) and p53 (53) had myc-tag (M) while T-antigen (T) and SLLP1 (S) had HA-tag (H). Co-IP of T-antigen or SLLP1 (arrows) was done using anti-myc
antibody from partner proteins. Co-IP reactions: T53, T-antigen+p53; SF, SLLP1+SAS1B-F; SN, SLLP1+SAS1B-N; SC, SLLP1+SAS1B-C.
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To further study interactions between SAS1B and SLLP1, co-IP was
performed using 35S-methionine labeled recombinant constructs. In
vitro translated N-term, C-term, full length SAS1B, and p53 had myc-
tags (M) while SLLP1 and T-antigen had HA-tags (H). Each produced a
major band at the expected mass by SDS-PAGE analyses (Supplementa-
ry Fig. 7A). SLLP1 (~16 kDa) was co-immunoprecipitated with an anti-
myc tag antibody to SAS1B full length, N- and C-terminal fragments
(Fig. 6A). In the reverse co-IP experiment, SAS1B full length (~50 kDa),
N- (~21 kDa) and C-terminal (~26 kDa) fragments were pulled down
by anti-HA tag antibody to SLLP1 (Supplementary Fig. 7B). As a positive
control, large T-antigen was co-immunoprecipitated with p53 taged
myc antibody (Fig. 6A). Together the results indicate that SLLP1 has
interacting domains with SAS1B.
Yeast two hybrid (Y2H) analyses
The Y2H system with stringent selection conditions was used to
study afﬁnity between rSLLP1 and three rSAS1B constructs: full
length 414 residues (V2), N-term 121 residues, and C-term 210 resi-
dues. Successful co-transfection by both plasmid constructs was con-
ﬁrmed by survival on the low stringency plate (Supplementary Fig.
6). Protein–protein interactions were conﬁrmed by survival and
formation of blue colonies on high stringency plates. Yeast cells co-Fig. 7. Y2H and native Co-IP analyses between SAS1B and SLLP1. Y2H assay showed afﬁnit
forming blue colonies indicated interaction between the proteins. (A) Positive interaction
and human lamin C. (C) Very weak interaction between full length SAS1B and SLLP1 with f
actions were noted between SLLP1 and N-terminal (D) or C-terminal forms (E). Native Co-IP
eluted IP products were probed with SLLP1 (CS) or SAS1B antibody (CE). Sperm–egg extrac
L2, immune IP; L3, preimmune IP. Arrows indicate SLLP1 (~14 kDa) or SAS1B (~45 kDa).transfectedwith SLLP1 andN-terminal SAS1B showed the fastest rescue
with strongest blue color by 3 and 5 days (Fig. 7D and Supplementary
Fig. 6D). Co-transfection of C-terminal SAS1B and SLLP1 also rescued
the cells within three days (Supplementary Fig. 6E, HS), however co-
transfection of full length SAS1B with SLLP1 did not rescue the yeast
cells in 3 days but only weakly in 5 days (Fig. 7C and Supplementary
Fig. 6C, HS). The relative lack of full length SAS1B interaction with
SLLP1 is likely due to the presence of the putative transmembrane
domain in SAS1B (Li et al., 1996; Luban and Goff, 1995). The results
in the Y2H system conﬁrm the strong molecular interaction between
N-terminal SAS1B and SLLP1.
Native (n) Co-IP analyses
To evaluate interaction between the native proteins, rat SLLP1 an-
tibody was used to precipitate nSAS1B from a mixture of mouse
sperm and egg extracts. Equal aliquots of the IP complexes were re-
solved, blotted and probed with guinea pig SLLP1 or SAS1B anti-
bodies. SLLP1 antibody precipitated both ~14 kDa SLLP1 and the
predominant ~45 kDa SAS1B (V2, V6; Fig. 7CS, CE, arrows) while
the pre-immune antibody did not (Fig. 7, L3). The SAS1B band was
reconﬁrmed with a human SAS1B propeptide antibody (Supplemen-
tary Fig. 7C). The results conﬁrmed interacting domains in native
SAS1B and SLLP1 molecules.y between SLLP1 and SAS1B fragments. Growth of yeast cells on high stringency plate
between T-antigen and its partner p53. (B) Negative interaction between T-antigen
ew small colonies but none visible at 3 days (Supplementary Fig. 6, HS). Positive inter-
of SAS1B frommixture of sperm and egg extracts using SLLP1 antibody. Equally divided
t IP by SLLP1 antibody revealed predominant ~45 kDa SAS1B. L1, sperm or egg extract;
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To determine if both recombinant and native SLLP1 co-localize
with SAS1B, zona intact M2 oocytes were incubated with rSLLP1 or
nSLLP1, washed, and probed with SAS1B antibody. Strong SAS1B sig-
nals were present in the microvillar region of the oolemma and weak-
ly in the perivitelline space [PVS] of the oocyte, and co-localized with
the major recombinant or native SLLP1 signal, which also diffusely
stained the PVS (Figs. 8A, B). The diffuse staining of SLLP1 and
SAS1B in the PVS is consistent with the presence of oolemmal micro-
villi and previous localization of CD9 in PVS of M2 oocytes (Miyado et
al., 2008). In sum, native SAS1B co-localizes with rSLLP1 and nSLLP1
binding sites on the oocyte membrane indicating interactions within
a shared domain.Fig. 9. Interaction afﬁnity between SAS1B and SLLP1. Binding curves were observed
when six different analyte concentrations of SAS1B (400 — top, 300, 200, 100, 50, 25
and 0 nM — bottom) were injected (arrow) for 3 min over immobilized SLLP1 at a
ﬂow rate of 30 μl/min in running buffer using Biacore 3000 system. Following the bind-
ing phase, the sensograms showed a very low dissociation of SAS1B from the chip.Afﬁnity between SAS1B and SLLP1
To further study afﬁnity between SAS1B and SLLP1, surface plas-
mon resonance was used to determine a dissociation constant. As
observed in Fig. 9, SAS1B was capable of binding with immobilized
SLLP1 in a concentration dependent manner, and very little dissocia-
tion was apparent. Kinetic evaluation of SAS1B interaction with six
different analyte concentrations (400, 300, 200, 100, 50, 25 nM)
using a 1:1 binding model, revealed a sub-nanomolar dissociation
constant (average KD=0.32 nM). The sub-nanomolar dissociation
constant indicated a high afﬁnity binding between SAS1B and SLLP1
(Felder et al., 1993; Xu et al., 2004).rSAS1B or its antibody inhibit in vitro fertilization (IVF)
To determine the effect of rSAS1B during IVF, capacitated sperma-
tozoa were pre-incubated with rSAS1B prior to insemination. A
statistically signiﬁcant reduction (~77%–89%, P≤0.008, df≥4) in fer-
tilization was observed in samples treated with 25 μg/ml or more of
SAS1B (Fig. 10A) when compared with puriﬁed recombinant Ecat1,
an egg cytoplasmic protein, (Supplementary Fig. 5, L4) or no protein
PBS controls. The difference in fertilization between PBS and Ecat1
controls was not statistically signiﬁcant. Similarly, when zona-intact
oocytes (n) were incubated with SAS1B immune antibody followed
by insemination, fertilization was signiﬁcantly reduced by 51% at 1:20
dilution (P≤0.005; df=6) or by 38% at 1:60 dilution of immune anti-
body (P≤0.02, df=4) compared to preimmune control (Fig. 10B).
These observations are in agreement with the previous inhibition of
mouse IVF by rSLLP1 or its antibody (Herrero et al., 2005) and suggest
interactions of SAS1B and SLLP1 during fertilization.Fig. 8. Co-localization of recombinant SLLP1 and native SLLP1 with SAS1B. M2 oocytes incu
bodies. SLLP1 (2) co-localized predominantly to the microvillar region of the mouse oole
merge of 2 and 3; blue, nucleus.Fertility reduction in SAS1B knockout mice
To determine the role of SAS1B in fertility in vivo, SAS1B protein
deﬁcient mice were produced by homologous recombination by
gene targeting (Fig. 11A). Knockout mice were genotyped using
exon 7 (WF) forward, neo forward (NF), and intron 7 reverse (WR)
primers (Fig. 11D). Mating of 18 pairs of heterozygous males and fe-
males produced 113 pups (55 males, 58 females) from which 26
(23%) were Sas1b+/+, 59 (52%) were Sas1b+/−, and 28 (25%) were
Sas1b−/−, an allele distribution found to be consistent with expected
Mendelian ratios of 1:2:1 with an average of 6.3 pups/litter. Both
male and female Sas1b−/− mice were viable, grew to adulthood and
appeared grossly normal. Sas1b−/− males were fertile, consistent
with oocyte-speciﬁc expression of SAS1B. In homozygous knockout
females, no SAS1B protein was detected by immunohistochemistry
in any growing follicle stage using guinea pig anti-SAS1B antibody
in ovary sections (Fig. 11B). Immunoﬂuorescence analysis of homozy-
gous knockout ovulated M2 eggs also conﬁrmed lack of SAS1B protein
in the microvillar domain (Fig. 11C). Thus homozygous mutant Sas1b
mice were functionally null for SAS1B protein in ovaries and oocytes.
To study the effect of gene deletion on fertility, Sas1b+/+ and Sas1b−/−
femaleswerematedwith one Sas1b+/+male per cage and cohorts eval-
uated for numbers of fetuses and live born pups. As shown in Table 1,
both fetuses and live pups in Sas1b−/−mice were reduced by 36% and
32%, respectively, compared to wild type Sas1b+/+mice. This subfertilebated with rSLLP1 (A) or nSLLP1 (B), washed and probed with SLLP1 and SAS1B anti-
mma marked by SAS1B localization (3). Panels: 1, phase; 2, SLLP1; 3, SAS1B; and 4,
Fig. 10. SAS1B mediated inhibition of mouse in vitro fertilization. (A) Capacitated mouse sperm was incubated with varying concentrations of rSAS1B prior to fertilization of
cumulus intact oocytes. The percentage of fertilized eggs decreased with increased concentration of SAS1B compared to controls including the oocyte cytoplasmic protein recom-
binant Ecat1 or PBS without proteins. (B) Inhibition of fertilization of zona-intact eggs in presence of SAS1B antibody (black bar) compared to pre-immune (white bar) controls.
Bars represent mean±SEM; numbers, eggs per group. Signiﬁcant P-value differences from no protein (PBS), recombinant Ecat1 (50 μg/ml) or preimmune controls were marked
with asterisk (*, P≤0.02 to 0.008).
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SAS1B is, in part, involved in female fertility.
Discussion
SAS1B is a SLLP1 binding partner during fertilization
Six lines of biochemical evidence indicate that SAS1B is an
oolemmal binding partner for sperm intra-acrosomal ligand SLLP1.
First, native SAS1B in oocyte extracts speciﬁcally bound to and was
eluted from rSLLP1 bait on the SPR chip (Supplementary Fig. 1). Sec-
ond, rSLLP1 bound to rSAS1B in far western analyses (Fig. 6). Third,
molecular interaction between SAS1B and SLLP1 was demonstrated
in the yeast two hybrid assay system (Fig. 7). Fourth, recombinant
SAS1B–SLLP1 interactions were shown by co-IP of SLLP1 with anti-
body to a SAS1B tag, and the reverse, using eukaryotic in vitro trans-
lation (Fig. 6). Fifth, native SAS1B co-immunoprecipitated with SLLP1
antibody from a mixture of sperm and egg extracts (Fig. 7). Sixth, a
sub-nanomolar dissociation constant (KD=0.32 nM) revealed a
high afﬁnity interaction between these molecules (Fig. 9). The
restricted microvillar localization of SAS1B in mature oocytes and
co-localization of SLLP1 to this region (Fig. 8), known to be involved
in sperm-egg binding and fusion (Evans et al., 2000), provides correl-
ative physiological support for in-vivo SAS1B–SLLP1 interaction. An
earlier report showed that SLLP1 is retained in 90% of acrosome
reacted sperm, binds to oocyte microvillar domain and that SLLP1
protein or antibody inhibited fertilization and sperm–egg binding at
the level of the oolemma in a dose dependent manner in mouse IVF
studies (Herrero et al., 2005). The present study also revealed a
dose dependent inhibition of fertilization in the presence of SAS1B
antibody or protein (Fig. 10). Notably, both SLLP1 (Herrero et al.,
2005) and SAS1B are exposed prior to sperm–egg fusion. Together
these observations suggest that SAS1B is an oolemmal binding part-
ner that interacts with the sperm intra-acrosomal ligand SLLP1 prior
to gamete fusion during fertilization.
SAS1B is an oocyte speciﬁc protein
Bio-informatic analyses of mouse EST databases [NCBI] show
expression of SAS1B exclusively in ovary, oocyte and zygote. Northern
analysis of multiple tissues revealed that SAS1BmRNA is ovary specif-
ic. In mouse ovary, SAS1B protein is conﬁned to ooplasm of second-
ary, pre-antral, and Graaﬁan follicles. Following fertilization, SAS1B
assumes a reduced patchy distribution on the surface of the zygote
and blastomeres of early embryos, but is virtually undetectable by
late blastocyst stage. Thus, both at protein and mRNA levels SAS1B
is speciﬁcally expressed only in the oocyte and early embryo, suggest-
ing it is a maternal effect gene expressed during oogenesis.Dynamic re-localization of SAS1B to the microvillar domain
SAS1B was localized throughout the ooplasm of germinal vesicle
stage oocytes and was concentrated symmetrically in a corona at
the oocyte periphery. SAS1B subsequently localized to the microvillar
domain of the oolemma in M2 arrested ovulated secondary oocytes.
These observations indicate that a dynamic re-organization of the
SAS1B domain occurs as the oocyte matures following meiosis I
resulting in two distinct regions of the oocyte plasma membrane;
i.e., the region that lacks microvilli and overlies the eccentrically
located meiotic spindle, and the microvillar region (Evans et al.,
1997). The development of this polarity with respect to SAS1B is par-
ticularly noteworthy, as sperm bind to and fuse with the oolemma in
the microvillar region.
Mouse SAS1B has a putative transmembrane domain (Supplemen-
tary Fig. 1). SAS1B antibody localized the protein on the microvillar
domain of ovulated live M2 oocytes and inhibited fertilization, sug-
gesting that the molecule is exposed at the cell surface. Further,
CHO-K1 cells transfected with full length SAS1B (Fig. 5) showed local-
ization to plasma membrane protrusions rather than the planar por-
tions of the cell surface. This observation directly correlates with
published reports regarding targeting of membrane proteins to sites
of membrane insertion in microvilli of epithelial cells and to plasma
membrane protrusions of non-epithelial cells (Weigmann et al.,
1997).
SAS1B is an active protease
Bioinformatic analysis predicted that SAS1B belongs to a metallo-
protease family due to its characteristic zinc binding active site signa-
ture. The observation of in vitro proteolytic activity of rSAS1B
conﬁrmed this prediction (Fig. 1 and Supplementary Fig. 3). Several
other metalloproteases have been reported in the ovary, and their
role in ovulation and formation and regression of the corpus luteum
has been noted (Goldman and Shalev, 2003). These metalloproteases
were localized either in theca interna or externa, interstitial glands,
germinal epithelium, granulosa or theca-interstitial cells and oocyte
cytoplasm (Robinson et al., 2001). Unlike GDF-9 (Dong et al., 1996)
SAS1B is the ﬁrst metalloprotease reported to be localized on the
oolemmal surface. These properties along with the known drugability
of metalloproteases suggest this molecule as a candidate contracep-
tive target.
Metalloproteases are known to be involved in cellular fusion
events and fertilization. In yeast, cell-cell fusion requires the zinc
metalloprotease gene, AXL1 (Elia and Marsh, 1998). In sea urchin,
the zinc chelator (1,10-phenanthroline) showed no effect on the
binding of acrosome reacted sperm to the oolemma but blocked
(>95%) subsequent membrane fusion (Roe et al., 1988). In mice,
Fig. 11. Generation of SAS1B deﬁcient mice. (A) Schematic representation of the targeting strategy of the Astl gene encoding SAS1B by homologous recombination. The targeting
construct used thymidine kinase (TK) as a negative selection, MC1 Neo as a positive selection and IRES LacZ as a marker along with 4.9 kb and 2.9 kb homologous arms. The selec-
tion cassette targeted 3 coding exons (light vertical bars) 5, 6 and 7 encoding 131 residues (SPF–ILP) of the normal allele. Genotyping primer positions in normal and mutant alleles
were indicated by arrow heads. (B) Immunohistochemical localization of SAS1B in wild type (1) and null (2) mice ovaries using anti-SAS1B guinea pig antibody conﬁrmed the loss
of SAS1B protein in oocytes within growing follicles of knockout animals. S, secondary follicles; P, primary follicles. (C) Immuno-ﬂuorescence localization of SAS1B in wild type
(1 and 2) and knockout (3 and 4) ovulated eggs showed lack of SAS1B in the microvillar domain of mature M2 egg in null mice. Panels: 1 and 3 phase; 2 and 4 merge image of
DAPI/ﬂuorescence. (D) Genotype PCR of genomic tail DNA using 3 primers (WF, WR, NF) producing a 361 bp product in wild type (+/+), a 477 bp product in null (−/−) and
both products in heterozygous mice. M, DNA mass ladder.
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effect on sperm egg binding or fusion. However, 1,10-phenanthroline,
a metalloprotease inhibitor, inhibited mouse sperm–egg fusion with-
out reducing sperm–egg binding, suggesting a critical role of mem-
brane metalloproteases in mammalian gamete fusion (Correa et al.,
2000).
SAS1B conservation in mammals and role in fertilization
Orthologous and homologous genes were identiﬁed in other
mammals and in lower organisms, respectively. In lower organisms,
homologous proteins were characterized as hatching enzymes
(Hiroi et al., 2004). In a previous report an astacin metalloproteinase
detected at the RNA level in human and mouse ovaries wastentatively called ovastacin and was predicted to have a role in hatch-
ing (Quesada et al., 2004). However, the expression of SAS1B begins
to decrease after fertilization and is virtually undetectable in blasto-
cysts prior to hatching (Fig. 4) and SAS1B RNA was not detected be-
yond 1.5 days postcoitum in preimplantation embryos (Quesada et
al., 2004). Together, the results point to a role of this protein in fertil-
ization, rather than in zonal hatching, suggesting that the name
SAS1B conveys its biological interactions better than ovastacin. The
intra-acrosomal protein SLLP1 is exposed and retained on the inner
acrosomal membrane of 90% acrosome reacted sperm (Herrero et
al., 2005). Thus, following zona penetration, acrosome reacted
sperm will display SLLP1 on the inner acrosomal membrane where
SLLP1 is expected to bind tightly with microvillar SAS1B to facilitate
fertilization. This hypothesis is strengthened by gene knockout
Table 1
Fertility reduction in SAS1B knockout mice.
Parent genotype Male, wild-type (+/+)
No./group Total fetusesa
or pupsb
Average fetuses or
pups/femalec
Fertilityd
(%)
Female, wild-type
(+/+)
20 124 6.2±0.65 100
Female, knockout
(−/−)
20 82 4.1±0.64⁎ 66.1
Each male was paired with a wild-type and a knockout female for two weeks and then
separated for fetal or pups count.
a Breeding done by Merck Research Laboratories. From 8 breeding pairs, the (+/+)
and the (−/−) females produced 56 and 36 fetuses (36% reduction), respectively.
b Breeding done by University of Virginia. From 12 breeding pairs, the (+/+) and
the (−/−) females produced 68 and 46 pups (32% reduction), respectively.
c Values are mean±SEM.
d Fertility was determined as a percentage of average fetal or litter size.
⁎ Signiﬁcantly different from wild-type mice, P≤0.01 (Student's t-test).
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female mice. This subfertile phenotype supports the hypothesis that
SLLP1 and SAS1B are sperm-egg binding partners involved in fertili-
zation. Because mice ovulate multiple oocytes each cycle and ovulate
nearly eight times as frequently as humans, the subfertile phenotype
seen in mice may be magniﬁed in a normally uni-ovular primate, such
as humans (Vjugina and Evans, 2008). The role of SAS1B in primate
models and in human infertility and subfertility should therefore be
studied further.
Conclusions
The study identiﬁed SAS1B as a novel oolemmal binding partner
(receptor) for sperm intra-acrosomal protein SLLP1 (ligand) and
sheds new insight into the molecular mechanism of sperm–egg inter-
action at the level of the oolemma prior to fusion and sperm
internalization.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.12.021.
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